81material signals today 173IPOs 66buybacks 19OFSNSE · IST

Signals

20:13PANACHEFinancial results for the period ended September 30, 2026Major
20:12KISSHTAllotment of 26493882 securities pursuant to Preferential Issue at its meeting held on October 23, 2026
20:05ASMSBoard of Directors at its meeting held on October 23, 2026, has decided to issue equity shares on rights…
19:56AEROENTERAcquisition announcedMajor
19:52CROMPTONAction(s) taken or orders passed
19:48TRUALTFinancial results for the period ended September 30, 2026
19:48TRENTBusiness divestment announced
19:40SHAKTIPUMPEarnings and operational update for the quarter and half year ended September 30, 2026
19:38UTIAMCFinancial results for the period ended September 30, 2026Major
19:17SAMMAANCAP(CIN: L65922DL2005PLC136029)
19:16EMBDLAllotment of an aggregate of 1,10,00,000 Equity Shares of the Company pursuant to the conversion of Warrants
19:12SAMMAANCAPRegarding payment of interest on Secured Redeemable Non-Convertible Debentures issued by the Company through…
19:11BPCLFinancial results for the period ended September 30, 2026Major
19:10NESCOFinancial results for the period ended September 30, 2026
19:07TIKONAFinancial results for the period ended September 30, 2026Major
19:07SAMMAANCAPHereby certify that our Company has made timely payment of interest amount in respect of the Secured…
19:06UNIECOMPress release dated October 23, 2026, titled "Audited (Standalone and Consolidated) Financial Results for the…Major
18:54RAMCOSYSFinancial results for the period ended September 30, 2026
18:45ARIHANTSUPRedemption of Secured Non-Convertible Debentures (NCDs) of the Company
18:43TREEHOUSEFinancial results for the period ended September 30, 2026Major

Latest

Material developments from NSE, interpreted by CapitSignal.

Today

Monday, 5 October 2026

Today Yesterday 7 days

43Material events 3Earnings 17Business 4Capital 11M&A 1Regulatory 6Distress

All Earnings

Dr. Agarwal's Health Care LimitedAGARWALEYE22:49ImprovingNotable

NCLT sanctions Dr. Agarwal’s Eye Hospital merger into Dr. Agarwal’s Health Care

Update 2 of 2 in a matter ongoing since 27 Aug 2025

M&Amerger

As filed

Dr. Agarwal's Health Care Limited has informed the Exchange about the receipt of Sanction from the Hon'ble NCLT, Chennai Bench towards the Scheme of Amalgamation between Dr. Agarwal s Eye Hospital Lim

Why it matters

CapitSignal interpretation

The sanction advances the merger from approval to implementation, subject to completion of Scheme conditions. The company will subsequently disclose the Effective Date, Record Date and share allotment under the share exchange ratio.

What happened

Fact

The NCLT Chennai Bench sanctioned the amalgamation of Dr. Agarwal’s Eye Hospital Limited with and into Dr. Agarwal’s Health Care Limited. The order was pronounced on September 30, 2026 and uploaded on October 05, 2026; the certified copy is awaited.

April 01, 2026Appointed Date
Scheme effective date, from opening of business
September 30, 2026NCLT order pronouncement
date the sanction order was formally pronounced
October 05, 2026Order upload date
date the NCLT order was uploaded on the NCLT website

Watch next

Fact

Receipt and publication of the certified NCLT order
Completion of conditions required for the Effective Date
Record Date and share allotment under the share exchange ratio

Full analysis Company memory

Kothari Sugars And Chemicals LimitedKOTARISUG21:04MixedNotable

NCLT directs Kothari Sugars shareholder and creditor meetings for merger with Kothari Petrochemicals

Update 2 of 2 in a matter ongoing since 19 Aug 2026

M&Amerger

As filed

Kothari Sugars And Chemicals Limited has informed the Exchange about the receipt of Order passed by the Honble National Company Law Tribunal, Chennai Bench, in connection with the proposed Scheme of A

Why it matters

CapitSignal interpretation

The filing marks procedural progress toward KSCL’s merger into KPL, but the scheme still requires shareholder, creditor and other necessary statutory and regulatory approvals.

What happened

Fact

The NCLT Chennai Bench allowed the joint first-motion application for Kothari Sugars and Chemicals’ proposed amalgamation into Kothari Petrochemicals. It directed meetings of equity shareholders and unsecured creditors of both companies on November 13, 2026 to consider the scheme; secured-creditor meetings were dispensed with after Indian Bank consented.

September 30, 2026NCLT order date
Order directing meetings for the proposed amalgamation
November 13, 2026Meeting date
Meetings of equity shareholders and unsecured creditors of KSCL and KPL

Watch next

Fact

Notices and voting details for the November 13, 2026 meetings
Shareholder and unsecured-creditor approval of the scheme
Remaining statutory and regulatory approvals

Full analysis Company memory

Kothari Petrochemicals LimitedKOTHARIPET19:23ImprovingNotable

NCLT orders shareholder and creditor meetings for Kothari Sugars merger

Update 2 of 2 in a matter ongoing since 19 Aug 2026

M&Amerger

As filed

Kothari Petrochemicals Limited has informed the Exchange about the receipt of Order passed by the Hon ble National Company Law Tribunal, Chennai Bench, in connection with the proposed Scheme of Amalga

Why it matters

CapitSignal interpretation

The order advances the proposed merger to stakeholder voting, a required step before the scheme can proceed. The transaction still requires necessary statutory and regulatory approvals.

What happened

Fact

The NCLT Chennai Bench allowed the joint first-motion application for the proposed amalgamation of Kothari Sugars and Chemicals into Kothari Petrochemicals. It directed both companies to convene meetings of equity shareholders and unsecured creditors on November 13, 2026; secured-creditor meetings were dispensed with after Indian Bank consented to the scheme.

September 30, 2026NCLT hearing and order date
NCLT allowed the first-motion application and pronounced its order
November 13, 2026Meeting date
Scheduled meetings of equity shareholders and unsecured creditors of both companies

Watch next

Fact

Shareholder and unsecured-creditor voting on November 13, 2026
Release of meeting notices and detailed scheme information
Further statutory and regulatory approvals for the scheme

Full analysis Company memory

DS Kulkarni Developers LimitedDSKULKARNI19:21Low

D S Kulkarni Developers acquires Westpole Spaces for ₹10,000

M&Aacquisition

As filed

DS Kulkarni Developers Limited has informed the Exchange about Acquisition of 100% Equity Stake in Westpole Spaces Private Limited

Why it matters

CapitSignal interpretation

The acquisition adds a wholly owned real-estate subsidiary, which the company says is intended to support business expansion and growth. However, the target has not started operations and has nil turnover, limiting immediate operating impact.

What happened

Fact

D S Kulkarni Developers acquired 100% of Westpole Spaces Private Limited on October 05, 2026, making it a wholly owned subsidiary. The cash acquisition cost was ₹10,000; Westpole is a newly incorporated real-estate company that has not commenced operations and reported nil turnover.

100%Acquisition stake
equity share capital acquired
Rs. 10,000/-Acquisition cost
cash consideration
Rs. 10,000/-Target paid-up capital
Westpole Spaces paid-up capital
NILTarget turnover
Westpole Spaces turnover

Watch next

Fact

Whether Westpole Spaces commences business operations
Any future projects or financial contribution from Westpole Spaces

Full analysis Company memory

Healthcare Global Enterprises LimitedHCG19:17Low

HCG clarifies promoter holdings after March rights issue and Hector encumbrance disclosure

M&Aacquisition

As filed

Healthcare Global Enterprises Limited has informed that Healthcare Global (Kenya) Private Limited ( HCG Kenya ), a step-down subsidiary of Healthcare Global Enterprises Limited ( Company ), has today,

Why it matters

CapitSignal interpretation

The filing reconciles discrepancies in reported promoter holdings and clarifies that Hector's financing-related restriction is treated as an encumbrance, while stating that no pledge has been created on the Company's shares.

What happened

Fact

HealthCare Global Enterprises said differences between its March 31, 2026 shareholding pattern and depository data arose because rights-issue shares allotted on March 27, 2026 were credited on April 1, 2026. It also clarified that Hector Asia Holdings II Pte. Ltd.’s 7,16,77,991 shares were reported as an encumbrance under a facility agreement, not as a pledge.

7,16,77,991 equity sharesHector shareholding acquired
shares acquired from Aceso Company Pte. Ltd. on May 30, 2025
~ 51.41%Hector ownership
stated proportion of the Company's total share capital
71677991Hector NDU holding in submitted shareholding pattern
NDU holding reported in Table II of the submitted shareholding pattern
5118036Hector rights shares allotted
additional shares allotted via rights issue

Watch next

Fact

Any subsequent updates to promoter shareholding following the April 1, 2026 credit of rights-issue shares
Further disclosures concerning Hector's facility agreement or encumbrance status

Full analysis Company memory

DS Kulkarni Developers LimitedDSKULKARNI19:03Low

D S Kulkarni Developers to acquire Westpole Spaces for Rs. 10,000

M&Aacquisition

As filed

DS Kulkarni Developers Limited has informed the Exchange regarding Outcome of Board Meeting held on October 05, 2026.

Why it matters

CapitSignal interpretation

The transaction gives the company full ownership of a real-estate entity, but the target has not commenced operations and has nil turnover. The disclosed financial commitment is limited to Rs. 10,000/-.

What happened

Fact

The board approved the acquisition of a 100% equity stake in Westpole Spaces Private Limited for cash consideration of Rs. 10,000, with completion indicated within 1 month. Westpole is a newly incorporated real-estate company with nil turnover that has not commenced operations; the company said the acquisition is intended to support business expansion and growth.

Rs. 10,000/-Acquisition consideration
cash cost of acquiring Westpole Spaces Private Limited
100%Stake acquired
equity stake and control proposed to be acquired
NILWestpole turnover
target company turnover
Rs. 10,000/-Target paid-up capital
Westpole Spaces paid-up capital
1 MonthIndicative completion period
expected acquisition completion timeline

Watch next

Fact

Completion of the 100% acquisition within the indicated 1-month period
Whether Westpole commences operations or contributes assets or business activity after acquisition

Full analysis Company memory

Jaykay Enterprises LimitedJAYKAY16:51MixedMinor

Jaykay Enterprises invests ₹25 crore in JK Defence preference shares

M&Aacquisition

As filed

Jaykay Enterprises Limited has informed the Exchange about acquisition of additional share capital in JK Defence & Aerospace Limited, Wholly owned Subsidiary of the Company

Why it matters

CapitSignal interpretation

The company has deployed ₹25 crore of rights-issue proceeds into its defence and aerospace subsidiary. The subsidiary is pre-operational with nil turnover, so execution of the stated use of proceeds will be central to translating this funding into operating activity.

What happened

Fact

Jaykay Enterprises acquired 25,00,000 additional preference shares of ₹100 each in its wholly owned subsidiary, JK Defence & Aerospace, for ₹25,00,00,000 in cash through a rights issue. JK Defence has yet to commence operations, and Jaykay’s ultimate shareholding remains 100%.

₹25,00,00,000Investment amount
cash consideration for additional preference shares
25,00,000Preference shares acquired
additional shares acquired pursuant to the rights issue
₹100Face value per share
preference share face value
100%Ownership after acquisition
Jaykay Enterprises' ultimate shareholding in JK Defence & Aerospace

Watch next

Fact

How JK Defence utilizes the funds under the objects stated in the August 25, 2026 Letter of Offer
Commencement of operations and initial revenue generation at JK Defence

Full analysis Company memory

Jaykay Enterprises LimitedJAYKAY16:48Low

Jaykay Enterprises invests Rs. 2 crore more in digital subsidiary

M&Aacquisition

As filed

Jaykay Enterprises Limited has informed the Exchange about acquisition of additional share capital in JK Digital & Advance Systems Private Limited, Wholly owned Subsidiary of the Company

Why it matters

CapitSignal interpretation

The company is deploying rights-issue proceeds into its Digital & IT Services subsidiary. As JK Digital remains wholly owned, the transaction does not alter control or ownership but increases funding available to the subsidiary for the stated rights-issue objects.

What happened

Fact

Jaykay Enterprises acquired 2,00,000 additional preference shares in its wholly owned subsidiary, JK Digital & Advance Systems Private Limited, for Rs. 2,00,00,000 in cash through the subsidiary’s rights issue. The transaction was completed on October 05, 2026 and does not change Jaykay Enterprises’ 100% ultimate shareholding in JK Digital.

Rs. 2,00,00,000Acquisition cost
cash paid for additional preference shares
2,00,000Preference shares acquired
additional shares acquired pursuant to the rights issue
Rs. 100Face value per share
face value of acquired preference shares
Rs. 47.49 LakhsJK Digital FY 2025-26 turnover
turnover of the wholly owned subsidiary

Watch next

Fact

JK Digital’s utilization of the funds under the amended rights-issue objects
Future operating and financial performance of JK Digital

Full analysis Company memory

Sai Parenterals LimitedSAIPARENT15:53ImprovingNotable

Sai Parenterals acquires 60% of Prathyak Laboratories for Rs. 15 crore

M&Aacquisition

As filed

Sai Parenterals Limited has informed the Exchange regarding a press release dated October 05, 2026, titled "Sai Parenterals Completes the Acquisition of R&D Facility Prathyak Laboratories".

Why it matters

CapitSignal interpretation

The purchase replaces a planned greenfield R&D centre, allowing the company to begin development work immediately rather than building a facility and assembling a team. The R&D platform is intended to support complex injectable and oncology products, expanded injectable production, and new-product commitments under Australian and New Zealand supply agreements.

What happened

Fact

Sai Parenterals has completed the acquisition of a 60% equity stake in Prathyak Laboratories Private Limited for Rs. 15 crore, funded by unutilised IPO proceeds. The operating R&D centre, now renamed Sai Prathyak Laboratories Private Limited, becomes a direct subsidiary and brings 28 research scientists plus a development pipeline of 150 SKUs across 86 molecules.

60%Equity stake acquired
stake acquired in Prathyak Laboratories Private Limited
Rs. 15 croreAcquisition consideration
purchase price, funded from unutilised IPO net proceeds
28Research scientists
scientific team at acquired R&D centre
150 SKUs across 86 moleculesDevelopment pipeline
pipeline brought by the acquired R&D centre
40%Residual stake
stake that may be acquired under a Right of First Refusal at the same valuation

Watch next

Fact

Whether the company exercises its Right of First Refusal to acquire the remaining 40% stake
Progress in converting the 150-SKU pipeline into commercial injectable products
Development of products for Australian and New Zealand supply agreements

Full analysis Company memory

Veranda Learning Solutions LimitedVERANDA13:56Low

J.K. Shah Commerce Education reconstitutes board and appoints new CFO and company secretary

Update 6 of 7 in a matter ongoing since 28 Mar 2025Procedural

M&Amerger

As filed

Veranda Learning Solutions Limited has informed the Exchange regarding ' Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)

Why it matters

CapitSignal interpretation

The governance and key-management structure of JSCEL is being established ahead of, or in connection with, the composite scheme involving Veranda Learning Solutions. The filing does not disclose any financial terms or change to the scheme’s economics.

What happened

Fact

J.K. Shah Commerce Education Limited (JSCEL), the resulting company under Veranda Learning Solutions’ composite scheme, approved a board reconstitution on October 05, 2026. Jitendra Kantilal Shah will become Chairman & Managing Director from October 06, 2026, while JSCEL also appointed two whole-time directors, four independent directors, a CFO and a Company Secretary & Compliance Officer; two non-executive directors will resign effective close of business on October 06, 2026.

3 consecutive yearsChairman & Managing Director term
Jitendra Kantilal Shah’s term effective October 06, 2026
2Whole-time director appointments
appointments effective October 05, 2026
4Independent director appointments
appointments effective October 06, 2026
2Director resignations
non-executive director resignations effective close of business on October 06, 2026

Watch next

Fact

Further progress or approvals under the composite scheme of arrangement
Any subsequent disclosures on JSCEL’s operations or financials

Full analysis Company memory

Embassy Developments LimitedEMBDL13:05ImprovingLow

Embassy Developments promoter Jitendra Virwani buys 348,500 shares on market

M&Aacquisition

As filed

Acquisition of Equity Shares by the Promoter of the Company - Disclosure pursuant to Regulation7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015.

Why it matters

CapitSignal interpretation

The promoter's open-market purchase increased his disclosed shareholding by 3,48,500 shares, though the resulting holding remains 0.10%.

What happened

Fact

Jitendra Virwani, promoter and Chairman & Non-Executive Director, acquired 3,48,500 equity shares of Embassy Developments through the open market on September 30, 2026. His disclosed holding rose from 10,34,470 shares (0.07%) to 13,82,970 shares (0.10%).

3,48,500 equity sharesShares acquired
open-market purchase on September 30, 2026
Rs. 1,99,28,015.71Transaction value
purchase value excluding taxes, brokerage and other charges
13,82,970 shares (0.10%)Post-transaction holding
promoter's disclosed holding after acquisition
10,34,470 shares (0.07%)Pre-transaction holding
promoter's disclosed holding before acquisition

Full analysis Company memory

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Watch next

Why it matters

What happened

Live special situations